Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of pronatal policies on sexual and reproductive health services: a protocol for a scoping review.

BMJ open·2026
Same author

Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximab.

British journal of haematology·2026
Same author

Methods of induction of labour: a network meta-analysis.

The Cochrane database of systematic reviews·2026
Same author

Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

The New England journal of medicine·2025
Same author

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.

The Lancet. Haematology·2025
Same author

Global and regional causes of maternal deaths 2009-20: a WHO systematic analysis.

The Lancet. Global health·2025

Related Experiment Video

Updated: Jun 6, 2026

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
05:33

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting

Published on: August 4, 2023

Magnesium sulphate versus diazepam for eclampsia.

Lelia Duley1, David J Henderson-Smart, Godfrey Ja Walker

  • 1Centre for Epidemiology and Biostatistics, University of Leeds, Bradford Institute for Health Research, Bradford Royal Infirmary, Duckworth Lane, Bradford, West Yorkshire, UK, BD9 6RJ.

The Cochrane Database of Systematic Reviews
|December 15, 2010
PubMed
Summary

Magnesium sulfate significantly reduces maternal death and seizure recurrence in women with eclampsia compared to diazepam. This anticonvulsant therapy offers improved outcomes for both mothers and newborns.

Related Experiment Videos

Last Updated: Jun 6, 2026

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting
05:33

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting

Published on: August 4, 2023

Area of Science:

  • Obstetrics and Gynecology
  • Neurology
  • Pharmacology

Background:

  • Eclampsia, a severe pregnancy complication characterized by seizures, necessitates effective anticonvulsant treatment.
  • Various anticonvulsants are employed to manage eclamptic seizures and prevent recurrence.

Purpose of the Study:

  • To compare the efficacy and safety of magnesium sulfate versus diazepam in managing eclampsia.
  • To evaluate the impact on maternal and perinatal outcomes.

Main Methods:

  • Systematic review of randomized controlled trials identified through the Cochrane Pregnancy and Childbirth Group's Trials Register and CENTRAL.
  • Included trials compared intravenous or intramuscular magnesium sulfate with diazepam in women diagnosed with eclampsia.
  • Data extraction and assessment were performed independently by two authors.

Main Results:

  • Magnesium sulfate use was associated with a significant reduction in maternal mortality (RR 0.59, 95% CI 0.38 to 0.92) and seizure recurrence (RR 0.43, 95% CI 0.33 to 0.55) compared to diazepam.
  • No significant differences were observed in perinatal or neonatal mortality rates.
  • Infants in the magnesium sulfate group showed better Apgar scores and fewer required intubation, with a shorter hospital stay.

Conclusions:

  • Magnesium sulfate is more effective than diazepam in reducing maternal death and seizure recurrence in women with eclampsia.
  • The findings support the use of magnesium sulfate as a primary treatment for eclampsia.